-+ 0.00%
-+ 0.00%
-+ 0.00%

MABWELL'S ADALIMUMAB BIOSIMILAR RECEIVES MARKETING APPROVAL IN INDONESIA

路透·12/31/2025 14:00:06

登錄查看新聞詳情